Mural Oncology
MA - WalthamBiotechnology
Focus: Mural Oncology is a private immunotherapy-focused biotech company headquartered in Waltham, MA, developing novel oncology treatments for solid tumors and hematologic cancers.
Profile data last refreshed 12h ago · AI intelligence enriched 2w ago
Open Jobs
13
Should You Work at Mural Oncology?
AI assessmentMural offers early-stage immunotherapy exposure but carries elevated restructuring risk post-layoff; best for risk-tolerant candidates betting on Phase 3 Nemvaleukin data.
Why Work Here
- Focused pipeline in Phase 2/3 with two lead programs (Nemvaleukin Alfa and ALKS 4230) addressing unmet oncology needs across multiple indications
- Early-stage biotech offers hands-on impact and potential equity upside before clinical catalysts materialize
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ALKS 4230
Advanced Solid TumorsClinical Trials (1)
NCT03861793A Dose Escalation and Cohort Expansion Study of Subcutaneously-Administered Cytokine ALKS 4230 (Nemvaleukin Alfa) as a Single Agent and in Combination With Anti-PD-1 Antibody (Pembrolizumab) in Subjects With Select Advanced or Metastatic Solid Tumors (ARTISTRY-2)
Phase 1/2Help build intelligence for Mural Oncology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.